Last update:

Overweight & Obesity news

Overweight & Obesity

Weight loss caused by common diabetes drug tied to 'anti-hunger' molecule in study

An "anti-hunger" molecule produced after vigorous exercise is responsible for the moderate weight loss caused by the diabetes medication metformin, according to a new study in mice and humans. The molecule, lac-phe, was discovered ...

Overweight & Obesity

8-hour time-restricted eating linked to a 91% higher risk of cardiovascular death

An analysis of over 20,000 U.S. adults found that people who limited their eating to less than 8 hours per day, a time-restricted eating plan, were more likely to die from cardiovascular disease compared to people who ate ...

Overweight & Obesity

US FDA approves Wegovy to cut risk of heart problems

The US Food and Drug Administration has given the green light for a popular anti-obesity drug to be used to prevent serious heart conditions for the first time, in a move likely to expand insurance coverage.

Overweight & Obesity

New weight loss pill more effective than Ozempic: Novo Nordisk

An experimental new weight loss pill from Danish pharmaceutical giant Novo Nordisk could be twice as effective as its blockbuster Ozempic and Wegovy jabs, early results from a small trial have suggested, sending the firm's ...